(Q34842108)

4 August 2017

1 reference

title

A sense of tumour for the immune system (English)

1 reference

4 August 2017

Stephen Todryk

1

1 reference

4 August 2017

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

107

1 reference

4 August 2017

1

1 reference

4 August 2017

1-4

1 reference

A fresh look at tumor immunosurveillance and immunotherapy.

4 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

An innate sense of danger

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Immunotherapeutic potential of whole tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2567.2002.01506.X

Induction of tumor-specific T cell memory by NK cell–mediated tumor rejection

21 January 2018

1 reference

12 December 2020

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

1 reference

12 December 2020

Heat shock proteins refine the danger theory

1 reference

12 December 2020

10.1046/J.1365-2567.2002.01506.X

Identifiers

DOI

1 reference

4 August 2017

0 references

1 reference

PubMed ID

12225356